Nov 05, 2019 - Botox, Juveederm fillers, Vraylar drive Allergan's (AGN) third-quarter sales, making up for loss of exclusivity on some brands and lower sales of eye drug, Restasis.
Nov 04, 2019 - Biotech valuation looks attractive amid a volley of good news. Investors can tap these stocks and ETFs.
Nov 04, 2019 - Let us take a look at five drug/biotech companies, which are supposed to release their quarterly results on Nov 5.
Nov 04, 2019 - Pricing erosion in U.S. generics market and rapid erosion in sales of Copaxone are likely to have hurt Teva's (TEVA) Q3 sales
Oct 31, 2019 - Bristol-Myers (BMY) beats both earnings and sales estimates in the third quarter, primarily on robust sales of Eliquis and Sprycel.
Oct 31, 2019 - The Zacks Analyst Blog Highlights: Alexion, Amgen, Gilead and AMAG
Oct 30, 2019 - Key highlights include earnings updates, collaboration deals, and regulatory and pipeline updates.
Oct 30, 2019 - AMGN earnings call for the period ending September 30, 2019.
Oct 29, 2019 - Amgen Inc. (NASDAQ:AMGN) Q3 2019 Earnings Conference Call October 29, 2019 5:00 PM ET Company Participants Arvind Sood - Vice President, Investor Relations Bob Bradway - Chairman & Chief Executive
Oct 29, 2019 - Is (AMGN) Outperforming Other Medical Stocks This Year?